SCHEMBL960405

SCHEMBL960405

Clc1ccc(CCOc2cccc(Cl)n2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.40
F10 P00742 1/20 0.39
IDO1 P14902 3/20 0.39
HTT P42858 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
INPPL1 O15357 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
PPP1CA P62136 1/20 0.38
CDK9 P50750 1/20 0.38
DYRK1A Q13627 1/20 0.38
DYRK2 Q92630 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28871742 0.86 PTGER1 (0.40) CYP1A2CYP2C9CYP2C19PTGER1
SCHEMBL963457 0.77 PTGDR (0.54) F10L3MBTL1NPC1CYP2C9PTGER1
SCHEMBL5214760 0.74 CDK9 (0.41) IDO1MAPTL3MBTL1CDK9DYRK1A
SCHEMBL10639597 0.74 S1PR4 (0.48) S1PR4SMN1; SMN2IDO1HTTTDP1
SCHEMBL29638800 0.73 PTGER1 (0.49) CYP1A2CYP2C9CYP2C19PTGER1
SCHEMBL20266502 0.73 PTGER1 (0.49) CYP1A2CYP2C9CYP2C19PTGER1
SCHEMBL27176935 0.73 GRM5 (0.39) CYP1A2CYP2C9CYP2C19PTGER1NR4A1
SCHEMBL27176781 0.73 PTGER1 (0.38) CYP1A2CYP2C9CYP3A4CYP2C19PTGER1
SCHEMBL30750551 0.73 PTGER1 (0.38) CYP1A2CYP2C9CYP3A4CYP2C19PTGER1
SCHEMBL13321697 0.73 S1PR4 (0.56) S1PR4TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 S1PR4 797/4885SMN1; SMN2 3368/4885F10 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.